Investors

Webcast ImageWebcast
Edge Therapeutics, Inc. at the Jefferies 2017 Global Healthcare Conference (Replay)
June 8, 2017 at 9:00 a.m. ET
Edge Therapeutics, Inc. at the Jefferies 2017 Global Healthcare Conference
Thursday, June 8, 2017 9:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Corporate Profile

Edge Therapeutics is a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening conditions.

We believe EG-1962, our lead product candidate, can fundamentally improve patient outcomes and transform the management of aneurysmal subarachnoid hemorrhage, or aSAH, which is bleeding around the brain due to a ruptured brain aneurysm. Read More

Lastest News

June 15, 2017 - Edge Therapeutics to Participate in the JMP Securities Life Science Conference
Read More
June 8, 2017 - Edge Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines Agency
Read More
June 2, 2017 - Edge Therapeutics to Present at Jefferies 2017 Global Healthcare Conference
Read More

Upcoming Events

There are currently no events scheduled.

More >>

Stock Information

EDGE (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Price$10.27
Change (%) Stock is Down 0.03 (0.00%)
Volume28,999
Data as of June 22, 2017 4:00 p.m. ET
Refresh quote

IR Contact

Gregory Gin
Email: ir@edgetherapeutics.com

Data provided by Nasdaq. Minimum 15 minutes delayed.

Printer Friendly Version Print PageE-mail this page Email PageRSS RSS FeedsE-mail Alerts Email AlertsView contacts IR Contacts